These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1092 related articles for article (PubMed ID: 31954490)
1. Epidemiology and surveillance for hepatocellular carcinoma: New trends. Singal AG; Lampertico P; Nahon P J Hepatol; 2020 Feb; 72(2):250-261. PubMed ID: 31954490 [TBL] [Abstract][Full Text] [Related]
2. Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort. Paranaguá-Vezozzo DC; Ono SK; Alvarado-Mora MV; Farias AQ; Cunha-Silva M; França JI; Alves VA; Sherman M; Carrilho FJ Ann Hepatol; 2014; 13(4):386-93. PubMed ID: 24927609 [TBL] [Abstract][Full Text] [Related]
3. Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. Tong MJ; Blatt LM; Kao VW J Gastroenterol Hepatol; 2001 May; 16(5):553-9. PubMed ID: 11350553 [TBL] [Abstract][Full Text] [Related]
4. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease. Beale G; Chattopadhyay D; Gray J; Stewart S; Hudson M; Day C; Trerotoli P; Giannelli G; Manas D; Reeves H BMC Cancer; 2008 Jul; 8():200. PubMed ID: 18638391 [TBL] [Abstract][Full Text] [Related]
5. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study. Hong TP; Gow PJ; Fink M; Dev A; Roberts SK; Nicoll A; Lubel JS; Kronborg I; Arachchi N; Ryan M; Kemp WW; Knight V; Sundararajan V; Desmond P; Thompson AJ; Bell SJ Med J Aust; 2018 Oct; 209(8):348-354. PubMed ID: 30309301 [TBL] [Abstract][Full Text] [Related]
6. Changing epidemiology of hepatocellular carcinoma in Asia. Goh GB; Chang PE; Tan CK Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):919-28. PubMed ID: 26651253 [TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates. Younossi Z; Stepanova M; Ong JP; Jacobson IM; Bugianesi E; Duseja A; Eguchi Y; Wong VW; Negro F; Yilmaz Y; Romero-Gomez M; George J; Ahmed A; Wong R; Younossi I; Ziayee M; Afendy A; Clin Gastroenterol Hepatol; 2019 Mar; 17(4):748-755.e3. PubMed ID: 29908364 [TBL] [Abstract][Full Text] [Related]
8. Viral hepatitis and hepatocellular carcinoma. Marrero CR; Marrero JA Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352 [TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma, a rapidly increasing public health problem: the Tulane experience 2003-2009. Tangutur NK; Medvedev SF; Regenstein F; Balart LA J La State Med Soc; 2011; 163(4):185-90. PubMed ID: 21954650 [TBL] [Abstract][Full Text] [Related]
11. New insights on non-B non-C hepatocellular carcinoma in mid Delta Region, Egypt. Abou El Azm AR; Yousef M; Mansour N; Awad A; El Dardiry S; Abdel Aziz I J Gastrointest Cancer; 2014 Sep; 45(3):276-83. PubMed ID: 24488435 [TBL] [Abstract][Full Text] [Related]
12. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region. Amarapurkar D; Han KH; Chan HL; Ueno Y; J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082 [TBL] [Abstract][Full Text] [Related]
13. Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans With Cirrhosis. Tayob N; Christie I; Richardson P; Feng Z; White DL; Davila J; Corley DA; Kanwal F; El-Serag HB Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1886-1893.e5. PubMed ID: 30557738 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma. Ren FY; Piao XX; Jin AL World J Gastroenterol; 2006 Aug; 12(29):4656-9. PubMed ID: 16937435 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Hepatocellular Carcinoma in Patients with Cryptogenic Versus Hepatitis B Etiology: A Study of 1079 Cases Over 3 Decades. Liew ZH; Goh GB; Hao Y; Chang PE; Tan CK Dig Dis Sci; 2019 Feb; 64(2):585-590. PubMed ID: 30327962 [TBL] [Abstract][Full Text] [Related]
16. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease. Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360 [TBL] [Abstract][Full Text] [Related]
17. Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis. Izzo F; Cremona F; Ruffolo F; Palaia R; Parisi V; Curley SA Ann Surg; 1998 Apr; 227(4):513-8. PubMed ID: 9563539 [TBL] [Abstract][Full Text] [Related]
18. Ultrasound screening for hepatocellular carcinoma in patients with advanced liver fibrosis. An overview. Dănilă M; Sporea I Med Ultrason; 2014 Jun; 16(2):139-44. PubMed ID: 24791845 [TBL] [Abstract][Full Text] [Related]
19. Surveillance for hepatocellular carcinoma: how can we do better? Hassett M; Yopp AC; Singal AG Am J Med Sci; 2013 Oct; 346(4):308-13. PubMed ID: 23426089 [TBL] [Abstract][Full Text] [Related]
20. Serum alpha-fetoprotein may have a significant role in the surveillance of hepatocellular carcinoma in hepatitis B endemic areas. Sinn DH; Yi J; Choi MS; Kim YJ; Gwak GY; Lee JH; Koh KC; Paik SW; Yoo BC Hepatogastroenterology; 2015; 62(138):327-32. PubMed ID: 25916058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]